ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

223
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
Refresh
06 Apr 2018 13:44

Japan Pharma: Upcoming Catalysts & Event Driven Trading Ideas

Takeda Pharmaceutical Co Ltd (4502 JP), Shionogi & Co Ltd (4507 JP), Nippon Shinyaku Co Ltd (4516 JP) , Sumitomo Dainippon Pharma Co (4506 JP),...

03 Apr 2018 15:41

Japan Pharma - Drug Price Revision in April 2018

Japan, after the US and China, is the world’s third largest pharma industry, worth ~$70b in 2016. However, according to research and consulting...

02 Apr 2018 21:47

Takeda + Shire - Highly Accretive Merger Considering Takeda’s Core Earnings

Announcement – Takeda, on March 28, 2018, confirmed that it is officially considering making an offer for Shire (NASDAQ: SHPG) and that it has time...

02 Apr 2018 10:16

Takeda Considers Swallowing Shire, a Somewhat Surprising Move That Could Make Strategic Sense

Japanese pharma firm Takeda Pharmaceutical Co Ltd (4502 JP) said it is officially considering making an offer for diversified rare-disease-focused...

Logo
185 Views
Share
29 Mar 2018 14:03

Japan Pharmaceutical - Sector Overview

Core coverage – relative valuations Takeda Pharmaceutical Co Ltd (4502 JP) (NB: Pre-Shire announcement | Pro-Forma analysis to be published...

x